G Leverger

3.1k total citations
77 papers, 1.9k citations indexed

About

G Leverger is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, G Leverger has authored 77 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Public Health, Environmental and Occupational Health, 23 papers in Hematology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in G Leverger's work include Acute Lymphoblastic Leukemia research (23 papers), Acute Myeloid Leukemia Research (15 papers) and Neuroblastoma Research and Treatments (10 papers). G Leverger is often cited by papers focused on Acute Lymphoblastic Leukemia research (23 papers), Acute Myeloid Leukemia Research (15 papers) and Neuroblastoma Research and Treatments (10 papers). G Leverger collaborates with scholars based in France, United States and Switzerland. G Leverger's co-authors include André Baruchel, Catherine Patte, Mary V. Relling, Gerald M. Woods, Susan M. Blaney, Gregory H. Reaman, Caroline A. Hastings, Marie‐Cécile Le Deley, Laurence Brugières and Bruce M. Camitta and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Kidney International.

In The Last Decade

G Leverger

72 papers receiving 1.8k citations

Peers

G Leverger
Jerry Z. Finklestein United States
Arnold J. Altman United States
David M. Mintzer United States
G Leverger
Citations per year, relative to G Leverger G Leverger (= 1×) peers Yves Pérel

Countries citing papers authored by G Leverger

Since Specialization
Citations

This map shows the geographic impact of G Leverger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Leverger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Leverger more than expected).

Fields of papers citing papers by G Leverger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Leverger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Leverger. The network helps show where G Leverger may publish in the future.

Co-authorship network of co-authors of G Leverger

This figure shows the co-authorship network connecting the top 25 collaborators of G Leverger. A scholar is included among the top collaborators of G Leverger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Leverger. G Leverger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schifferli, Alexandra, Nathalie Aladjidi, Guillaume Moulis, et al.. (2024). Adolescents and Young Adults with Secondary Chronic Immune Thrombocytopenia: A Switzerland/France Collaboration Project. Blood. 144(Supplement 1). 548–548.
2.
Heritier, Sébastien, et al.. (2021). Prise en charge des leucémies pédiatriques. Soins Pédiatrie/Puériculture. 42(320). 35–40. 1 indexed citations
3.
Ducassou, Stéphane, Helder Fernandes, G Leverger, et al.. (2020). Second‐line treatment trends and long‐term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years. British Journal of Haematology. 189(5). 931–942. 13 indexed citations
5.
Hjalgrim, Lisa Lyngsie, Jacob Nersting, Jörg Breitkreutz, et al.. (2015). Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children. European Journal of Pharmaceutical Sciences. 83. 1–7. 6 indexed citations
6.
Creutzig, Ursula, Martin Zimmermann, Michael Dworzak, et al.. (2014). The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01. Haematologica. 99(9). 1472–1478. 31 indexed citations
7.
Landman‐Parker, Judith, et al.. (2009). Que savons-nous de la cellule leucémique ?. Bulletin de l Académie Nationale de Médecine. 193(7). 1501–1507. 1 indexed citations
8.
Bertrand, Yves, Françoise Méchinaud, Benoît Brethon, et al.. (2008). SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) Recommendations for the Management of Tumor Lysis Syndrome (TLS) With Rasburicase: An Observational Survey. Journal of Pediatric Hematology/Oncology. 30(4). 267–271. 12 indexed citations
9.
Leverger, G, et al.. (2005). Prise en charge sociale des enfants en provenance d'un pays étranger : l'expérience d'un service spécialisé. Archives de Pédiatrie. 12(6). 856–857. 4 indexed citations
10.
Steffen, Christoph A., Marie-Françoise Auclerc, Anne Auvrignon, et al.. (2004). Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons; a case-control study. Occupational and Environmental Medicine. 61(9). 773–778. 109 indexed citations
11.
Montravers, Françoise, Judith Landman‐Parker, Dany Grahek, et al.. (2002). [18F]FDG in childhood lymphoma: clinical utility and impact on management. European Journal of Nuclear Medicine and Molecular Imaging. 29(9). 1155–1165. 95 indexed citations
12.
Tabone, Marie‐Dominique, et al.. (2001). Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?. PubMed. 7(3). 538–43. 29 indexed citations
13.
Firat, Hüseyin, Rémi Favier, Mircéa Adam, et al.. (2001). Determination of Myeloid Antigen Expression on Childhood Acute Lymphoblastic Leukaemia Cells: Discrepancies Using Different Monoclonal Antibody Clones. Leukemia & lymphoma. 42(1-2). 75–82. 10 indexed citations
14.
Gebhard, F., G Leverger, Ross Pinkerton, et al.. (1998). High efficacy of recombinant urate oxidase in prevention of renal failure related to tumor lysis syndrome (TLS).. Blood. 92(10). 9 indexed citations
15.
Donadieu, Jean, Marie-Françoise Auclerc, André Baruchel, et al.. (1998). Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. British Journal of Haematology. 102(3). 729–739. 65 indexed citations
16.
Leverger, G, et al.. (1998). Advances in the management of malignancy-associated hyperuricaemia. British Journal of Cancer. 77(S4). 18–20. 59 indexed citations
17.
Rubie, H, Jean Michon, Dominique Plantaz, et al.. (1998). Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. British Journal of Cancer. 77(12). 2310–2317. 25 indexed citations
18.
Quartier, Pierre, C Courpotin, Catherine Dollfus, et al.. (1996). Diagnostic précoce et traitement d'une polyradiculonévrite à cytomégalovirus chez un enfant infecté par le VIH. Archives de Pédiatrie. 3(8). 792–795. 3 indexed citations
19.
Antignac, Corinne, Marie-Claire Gübler, G Leverger, et al.. (1989). Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney International. 35(6). 1336–1344. 107 indexed citations
20.
Schaison, G & G Leverger. (1986). [Treatment of acute lymphoblastic leukemia in children].. PubMed. 36(37). 2179–86. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026